MFS
ATOS icon

Mirabella Financial Services’s Atossa Therapeutics ATOS Stock Holding History

Mirabella Financial Services’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,421
Closed -$705K – 403
2021
Q3 		$705K Buy
+14,421
New +$839K 0.09% 198

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mirabella Financial Services's ATOS Position: Q4 2021 in Review

Mirabella Financial Services sold out of Atossa Therapeutics (ATOS) in Q4 2021, closing a stake of 14,421 shares — an estimated $705K sold.

Mirabella Financial Services first reported a position in ATOS in Q3 2021 and held it in 1 quarter. The position peaked at $705K in Q3 2021. 91 funds tracked by Wall St. Rank hold ATOS as of Q4 2021.

  • Mirabella Financial Services reported no remaining Atossa Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 14,421 Atossa Therapeutics shares in Q4 2021, an estimated $705K.
  • Mirabella Financial Services first reported a position in Atossa Therapeutics in Q3 2021 and held it in 1 quarter.
  • Mirabella Financial Services's Atossa Therapeutics position peaked at $705K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2021.

Based on Mirabella Financial Services's 13F filing for Q4 2021, filed 14 Feb 2022.